54 results
Page 2 of 3
8-K
EX-1.1
fvw03d1lqgmrsjmnsz
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
8-K
EX-1.2
0ducpdpq 52sa9l
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
424B5
ts0ryoid16yk
19 May 20
Prospectus supplement for primary offering
5:11pm
424B5
tyevptw
19 May 20
Prospectus supplement for primary offering
5:08pm
424B5
kv441im sjvzu
18 May 20
Prospectus supplement for primary offering
4:16pm
424B5
4e0rj
18 May 20
Prospectus supplement for primary offering
4:11pm
8-K
EX-99.1
chryh
12 May 20
Gossamer Bio Announces First Quarter 2020 Financial Results and Provides Corporate Update
4:18pm
8-K
EX-99.1
7moc1yn lubp2
24 Mar 20
Gossamer Bio Announces Fourth Quarter and Full-Year 2019 Financial Results and Provides Business Update
8:45am
8-K
nsg yftawlf
30 May 19
Departure of Directors or Certain Officers
8:00am
8-K
EX-10.1
ls5vlam s6v3vxrz
3 May 19
Gossamer Bio Secures Debt Facility for Up to $150 Million
4:00pm
DEF 14A
fmfwqfrp7xxnnqukod2q
30 Apr 19
Definitive proxy
4:04pm
10-K
qaligqjj1 dxefrd8c89
22 Mar 19
Annual report
4:45pm
424B4
87ldza9
8 Feb 19
Prospectus supplement with pricing info
4:40pm
CORRESP
k2x8vs9lw n1cgzyega
5 Feb 19
Correspondence with SEC
12:00am